3 results
Approved WMORecruiting
The objective of this prospective, observational study is to ensure the safety and the wellbeing of subjects treated with the NEVO* SES.
Approved WMORecruiting
Primary:To compare the efficacy of asciminib versus Investigator selected TKI with respect to the proportion of patients that are in Major Molecular Response at Week 48. To compare the efficacy of asciminib versus Investigator selected TKI, within…
Approved WMORecruiting
The overall aim of this study is to better understand the impact of symptomatic and asymptomatic episodes of hypoglycaemia on people living with diabetes.